AstraZeneca PLC
AZN
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kā¦ read more
Healthcare
Drug ManufacturersāGeneral
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$169.64
Price-0.99%
-$1.70
1Y
Price
Market Cap
$131.471b
Large
Price/Earnings 3y Avg5y Avg
18.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+37.1%
EBITDA Margin+20.2%
Net Profit Margin+11.9%
Free Cash Flow Margin+37.1%
EBITDA Margin+20.2%
Net Profit Margin+11.9%
Free Cash Flow MarginRevenue
$61.366b
+2.9%
1y CAGR+9.9%
3y CAGR+8.2%
5y CAGREarnings
$10.446b
+1.3%
1y CAGR+21.7%
3y CAGR+36.6%
5y CAGREPS
$13.32
+1.5%
1y CAGR+21.7%
3y CAGR+36.4%
5y CAGRBook Value
$50.311b
$115.698b
Assets$65.387b
Liabilities$32.201b
DebtDebt to Assets
27.8%
1.7x
Debt to EBITDAFree Cash Flow
$8.740b
-6.9%
1y CAGR+7.7%
3y CAGR+3.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company